Video Library - Pricing
F. Randy Vogenberg, RPh, PhD
Lead Collaborator
National Institute of Collaborative Healthcare
Greenville, SC
Adjunct Assistant Professor
Pharmacy Administration
Health Economics Research
University of Illinois
College of Pharmacy
Chicago IL
Randy Vogenberg discusses the challenge of covering cancer care as survivorship increases
Related Items
The Value of Pre–FDA Approval Healthcare Economic Information Exchange Between Payers and Drug Manufacturers
Peter R. Fendt, PharmD, MBA, Brian Ung, PharmD, RPh, F. Randy Vogenberg, RPh, PhD
November 2017 Vol 10, No 8 published on November 21, 2017 in Industry Trends
Economic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers
Burton S. Brodsky, MD, Gary M. Owens, MD, Dennis J. Scotti, PhD, MBA, Keith A. Needham, BS, Christina L. Cool, MPH
October 2017 Vol 10, No 7 published on November 9, 2017 in Business, Original Research
Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis
Kumar Mukherjee, PhD, Khalid M. Kamal, PhD
February 2017 Vol 10, No 1 published on February 17, 2017 in Business
Top 10 Healthcare Market Trends in 2017
John Santilli, MBA, F. Randy Vogenberg, RPh, PhD
February 2017 Vol 10, No 1 published on February 17, 2017 in Industry Trends
Employer Perspectives on a Specialty Drug Step-Therapy Program Evaluation
Matthew Harman, PharmD, MPH, F. Randy Vogenberg, RPh, PhD
September 2016 Vol 9, No 6 published on September 15, 2016 in Industry Trends
Last modified: March 24, 2015
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME